Journal
NEUROLOGY
Volume 60, Issue 10, Pages 1710-1713Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/01.WNL.0000061483.11417.1B
Keywords
-
Categories
Ask authors/readers for more resources
The authors found that fluoxetine significantly shortens at 5 muM/L and nearly normalizes at 10 muM/L the prolonged opening bursts of slow-channel congenital myasthenic syndrome (SCCMS) acetylcholine receptors (AChR) expressed in fibroblasts. Prompted by this observation, they treated two SCCMS patients allergic to quinidine with up to 80 to 120 mg of fluoxetine per day over 3 years (serum fluoxetine + norfluoxetine levels 8 to 11 muM/L). Both patients showed marked subjective and objective improvement by quantitative muscle strength testing and electromyography.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available